Virology Journal

official impact factor 2.55

Open Access Research

Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

Glen J Mcintyre1*, Yi-Hsin Yu1, Anna Tran1, Angel B Jaramillo1, Allison J Arndt1, Michelle L Millington1, Maureen P Boyd1, Fiona A Elliott1, Sylvie W Shen1, John M Murray2,3 and Tanya L Applegate1

Author Affiliations

1 Johnson and Johnson Research Pty Ltd, Level 4 Biomedical Building, 1 Central Avenue, Australian Technology Park, Eveleigh, NSW, 1430, Australia

2 School of Mathematics and Statistics, The University of New South Wales, Sydney, NSW, 2052, Australia

3 The National Center in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria St. Darlinghurst, NSW, 2010, Australia

For all author emails, please log on.

Virology Journal 2009, 6:184 doi:10.1186/1743-422X-6-184

Published: 30 October 2009

Abstract

Background

Multiple short hairpin RNA (shRNA) gene therapy strategies are currently being investigated for treating viral diseases such as HIV-1. It is important to use several different shRNAs to prevent the emergence of treatment-resistant strains. However, there is evidence that repeated expression cassettes delivered via lentiviral vectors may be subject to recombination-mediated repeat deletion of 1 or more cassettes.

Results

The aim of this study was to determine the frequency of deletion for 2 to 6 repeated shRNA cassettes and mathematically model the outcomes of different frequencies of deletion in gene therapy scenarios. We created 500+ clonal cell lines and found deletion frequencies ranging from 2 to 36% for most combinations. While the central positions were the most frequently deleted, there was no obvious correlation between the frequency or extent of deletion and the number of cassettes per combination. We modeled the progression of infection using combinations of 6 shRNAs with varying degrees of deletion. Our in silico modeling indicated that if at least half of the transduced cells retained 4 or more shRNAs, the percentage of cells harboring multiple-shRNA resistant viral strains could be suppressed to < 0.1% after 13 years. This scenario afforded a similar protection to all transduced cells containing the full complement of 6 shRNAs.

Conclusion

Deletion of repeated expression cassettes within lentiviral vectors of up to 6 shRNAs can be significant. However, our modeling showed that the deletion frequencies observed here for 6× shRNA combinations was low enough that the in vivo suppression of replication and escape mutants will likely still be effective.